Table 1 Demographic and baseline characteristics of the groups
Characteristic | rESWTa (n = 13) | LCsIb (n = 12) | p value |
|---|---|---|---|
Age, median (mean +/− SD), y | 46 +/−  9 | 53 +/−  12 | 0.12 |
Gender, n (%) | Â | Â | 0.16 |
 Male | 5 (62) | 1 (8) |  |
 Female | 8 (38) | 11 (92) |  |
Body mass index, (mean +/− SD) | 28 (5) | 24 (3) | 0.09 |
Lesion site, n (%) |  |  | > 0.99 |
 Right | 9 (69) | 8 (67) |  |
 Left | 4 (31) | 4 (33) |  |
 Unilateral | 9 (69) | 12 (100) |  |
 Bilateral | 4 (31) | 0 |  |
Severity, n (%) |  |  | > 0.99 |
 Mild | 5 (62) | 4 (33) |  |
 Moderate | 8 (38) | 8 (67) |  |
Baseline visual analogue scale, (mean +/− SD) | 2.4 +/− 2.5 | 2.6 +/−  2.0 | 0.60 |
Baseline symptom severity score, (mean +/− SD) | 21 +/−  6.4 | 22 +/−  5.1 | 0.63 |
Baseline functional score, (mean +/− SD) | 14 +/−  3.2 | 12 +/−  4.1 | 0.16 |
Baseline Boston questionnaire score, (mean +/− SD) | 35 +/−  8.5 | 34 +/−  8.5 | 0.77 |
Baseline peak sensory distal latency, (mean +/− SD) | 4.5 +/−  0.72 | 3.7 +/−  1.3 | 0.057 |
Baseline SNAPc amplitude, (mean +/− SD) | 17 +/−  6.9 | 18 +/−  10 | 0.72 |
Baseline motor distal latency, (mean +/− SD) | 4.5 +/−  0.35 | 4.7 +/−  0.90 | 0.57 |
Baseline CMAPd amplitude, (mean +/− SD) | 6.9 +/−  1.5 | 6.0 +/−  0.61 | 0.16 |